Polyomaviruses are a family of small, non-enveloped DNA viruses that can cause severe 27 disease in immunosuppressed individuals. Studies with SV40, a well-studied model 28 polyomavirus, have revealed the role of host proteins in polyomavirus entry and trafficking to 29 the nucleus, viral transcription and DNA replication, and cell transformation. In contrast, little 30 is known about host factors or cellular signaling pathways involved in the late steps of 31 productive infection leading to polyomavirus release. We previously showed that cytoplasmic 32 vacuolization, a characteristic late cytopathic effect of SV40, depends on the specific 33 interaction between the major viral capsid protein VP1 and its cell surface ganglioside 34 receptor GM1. Here we show that late during infection, SV40 activates a signaling cascade in 35 permissive CV-1 monkey cells involving Ras, Rac1, MKK4 and JNK to induce SV40-specific 36 cytoplasmic vacuolization and subsequent cell lysis and virus release. Inhibition of individual 37 components of this signaling pathway inhibits vacuolization, lysis and virus release, even 38 though high-level intracellular virus replication occurs. The identification of this pathway for 39 SV40-induced vacuolization and virus release provides new insights into the late steps of non-40 enveloped virus infection and reveals potential drug targets for the treatment of diseases 41 caused by these viruses. 42 43 -3-
-8-vacuoles (arrows) (Figs. 1C and 1D, regions of interest (ROI) ), suggesting the existence of 152 complex vesicular structures containing GM1 in infected cells. 153
To visualize the dynamics of vacuole formation and maturation, we conducted live--9-(Supplemental Fig. S1 ). These results indicate that Ras signalling is required for SV40-177 induced vacuole formation but not for SV40 infection. 178 179
Vacuolization precedes cell lysis and SV40 release 180
To study the temporal relationship between SV40-induced vacuolization and progression of 181 the virus life cycle, CV-1 cells were infected with wild-type SV40 at MOI 10, and 182 vacuolization was monitored every 12 hours by bright-field microscopy. Small vacuoles first 183 appeared at 36 h.p.i., with a pronounced vacuolization evident by 48 h.p.i. (Fig. 4A, C) . 184
Vacuolization reached a plateau at around 60 h.p.i. As expected, the appearance of vacuoles 185 correlated with the expression of VP1, which became prominent around 36 h.p.i. as assessed 186 by immunoblotting and grew stronger at later times (Fig. 4B) . 187
To examine the temporal relationship between virus production and vacuole 188 formation, we measured cell-associated and released infectious SV40. We infected CV-1 cells 189 with SV40 at MOI of 10, and at various times p.i. the supernatant was collected as a source of 190 released virus. At the same time points, the cells were lysed by freeze-thawing as a source of 191 cell-associated virus. Infectious virus in both samples was quantified by infecting naïve cells and enumerating large T antigen-positive cells by flow cytometry 24 h.p.i. As shown in 193 Fig. 4C , the timing and extent of vacuolization was virtually congruent with the production of 194 cell-associated virus, which first appeared at 36 h.p.i. In contrast, significant amounts of 195 infectious SV40 in the supernatant were first detected 48 h.p.i. and continuously increased 196 until the end of the observation period at 72 h.p.i. Finally, we assessed cell lysis by measuring 197 the release of the intracellular enzyme lactate dehydrogenase (LDH) into the supernatant. 198 LDH levels in the supernatant coincided with released SV40 (Fig. 4C ). Thus, cell lysis and 199 release of significant amounts of virus lag approximately 12 hours behind intracellular virus 200 production and vacuolization. 201 -10-
SV40 induces MAPK signaling late during infection 203
Infection by polyomaviruses at high MOI transiently activates cellular mitogenic 204 signaling pathways, including the MAP kinase pathways, which are triggered by Ras 205 activation (9-12). To determine whether the MAP kinase pathway was activated at late times 206 after SV40 infection, when vacuoles typically form, we used phospho-site specific antibodies 207 and western blotting to examine phosphorylation of the signaling proteins JNK, p38, and 208 ERK. At 48 h.p.i., pronounced phosphorylation of JNK (Thr183/Tyr185), p38 209 (Thr180/Tyr182) and ERK (Thr202/Tyr204) was observed ( Fig. 5A ), with little difference in 210 the total amount of these proteins, indicating broad activation of these signaling pathways in 211 response to SV40 infection. We also examined the time course of MAP kinase signaling by 212 analysing a series of time points beginning at 12 h.p.i., long after the acute phase of signaling 213 has terminated. This analysis revealed the presence of progressive phosphorylation of JNK, 214 ERK and p38 beginning as early as 24 h p.i. (Fig. 5B ). Activation of signaling pathways at 215 cell membranes can lead to JNK1/2 phosphorylation through the action of MKK4, a 216 membrane-proximal kinase. To determine the phosphorylation status of the MKK4 during 217 SV40 infection, we conducted western blot analysis of MKK4 phosphorylation at serine 257 218 and threonine 261. This analysis revealed the presence of phospho-MKK4 by 48 h.p.i. (Fig. 219 5B) . Although MKK4 phosphorylation was detected at later times than JNK phosphorylation, 220
we believe that this is due to the lower sensitivity of the phospho-MKK4 antibody. After 221 phosphorylation, activated MAP kinases translocate into the nucleus and regulate gene 222 expression by phosphorylating transcription factors such as ATF-2 and c-Jun. Consistent with 223 activation of MAP kinase signaling, ATF-2 and c-Jun were phosphorylated late during SV40 224 infection, when VP1 expression became abundant ( Fig. 5B) . 225
To determine the role of specific signaling pathways in vacuolization and SV40 release, we 228 tested whether chemical and genetic inhibitors that blocked signaling affected these processes. 229
Starting at 12 h.p.i., CV-1 cells were treated with chemical inhibitors targeting JNK 230 (SP600125), p38 (SB203580) and MEK (Selumetinib), a key component of the ERK 231 pathway. Inhibitory activity was confirmed by western blot analysis showing reduced target 232 protein phosphorylation 48 h.p.i. (Fig. 6A ). Vacuolization of cells treated with the inhibitors 233 was examined two days p.i. Strikingly, the JNK inhibitor, SP600125, completely blocked 234 vacuole formation, whereas p38 inhibition had no effect compared to vehicle alone (Figs. 6B 235 and 6C). The ERK pathway inhibitor caused a significant reduction in vacuolization, but 236 strong cytotoxic effects were observed during treatment of non-infected cells with this 237 compound (Supplemental Fig. S2A ). We conclude that the lack of vacuoles in ERK-inhibited 238 cells is likely a consequence of accelerated cell death and detachment of cells rather than a 239 true suppression of vacuolization. 240
Inhibition of JNK also inhibited SV40-induced cell lysis by 50% ( Fig. 6D ) and caused 241 a 6-fold reduction of SV40 release with respect to cell-associated virus (Figs. 6E, S2B, and 242 S2C). In contrast, treatment of infected cells with the MEK or p38 inhibitor did not reduce 243 cell lysis or SV40 release. Treatment of cells with inhibitors did not interfere with early steps 244 of SV40 infection as assessed by flow cytometry for large T antigen expression 245 (Supplemental Fig. S2D ), suggesting that the JNK signaling pathway is specifically required 246 late in infection for vacuolization, cell lysis, and efficient virus release. 247
To assess the role of MKK4 in SV40-induced vacuolization and virus release, we used 248 three shRNAs with different mkk4 target sequences to generate CV-1 cells with stable MKK4 249 knock-down ( Fig. 7A ). For example, virus binding to its surface receptor often triggers signaling cascades that 271 facilitate virus entry and replication. We previously reported that intracellular SV40 VP1 272 expression alone does not induce vacuolization and that SV40 particles and VP1 are absent 273 from the vacuolar lumen in infected CV1 cells or CV1 cells undergoing vacuolization in 274 response to acute treatment with VP1 pentamers (17). These findings suggest that 275 vacuolization is the result of a signaling cascade triggered at the cell surface. In this report, 276
we show that in addition to signaling occurring early in infection, SV40 also induces the 277 MAPK signaling cascade during the late stage of infection when large amounts of VP1 278 accumulate to support vacuolization and efficient virus release. 279
Several findings reported here suggest that progeny SV40 particles bind to GM1 at the 280 plasma membrane and trigger GM1-dependent Ras activation and vacuolization to support 281 further virus release. Live cell microscopy of SV40-infected CV-1 cells revealed that SV40-282 induced vacuoles display a dynamic endocytic nature, consistent with vacuolization having a 283 signaling basis. We also show that VP1 co-localizes with GM1 and Ras at the limiting 284 membrane of SV40-induced vacuoles arising late in infection. Most importantly, we showed 285 that dominant-negative Ras S17N or inhibition of JNK signaling inhibits vacuole formation. 286
Overall, we hypothesize that in response to SV40-induced clustering of GM1, Ras is activated 287 and triggers MAPK signaling through Rac1-MKK4-JNK, which results in vacuolization and 288 subsequent cell lysis and virus release. 289
Previously published work is consistent with this model. GM1 clustering has been 290 reported to modify active HRas distribution in membrane nanodomains (26), and 291 overexpression of constitutively-active HRas (HRas G12V) leads to extensive vacuolization 292 in glioblastoma cells, with Ras localized at the limiting membrane of cytoplasmic vacuoles 293 (22, 23) . Like vacuoles formed during SV40 infection, HRas-induced vacuole formation in -14-glioblastoma cells was independent of ERK signaling (23) and blocked by chemical inhibition 295 of Rac1(27) . Furthermore, in both Ras-activated glioblastoma cells and SV40-infected cells, 296 vacuoles contain markers such as Lamp-1 and undergo extracellular fluid uptake resembling 297 macropinocytosis (22, 23, 28) . 298
Although Ras and VP1 co-localize in vacuolar membranes (Fig. 1C) , we have not 299 determined the cellular compartment where GM1-dependent Ras activation occurs during 300 SV40 infection. GM1 can localize to several different membrane compartments including the 301 plasma membrane, Golgi network and the ER, and the ceramide structure of GM1 influences 302 its trafficking into various cellular compartments (29) experiments revealed that only the JNK pathway is essential for vacuolization, cell lysis and 318 efficient virus release. Importantly, inhibition of JNK, Ras, and MKK4 activity or expression 319 did not interfere with SV40 entry and intracellular replication, so the impaired late events do -15-not merely reflect an early replication block. This is consistent with an earlier published report 321 that MAPK/ERK signaling is not required for the early response to SV40 infection (12) and 322 with a recent genome-wide analysis of kinases that contribute to SV40 endocytosis, which did 323 not detect a requirement for MAPK signaling (13). We conclude that Ras-Rac1-MKK4-JNK 324 signaling is essential late during SV40 infection for vacuolization and cell death leading to 325 virus release, whereas other signaling pathways are dispensable. 326
In agreement with previous studies (33), we showed that infectious SV40 first appears 327 at low levels in the supernatant as early as 36 h.p.i. The release of virus at this early time 328 might occur due to the first cells that lyse or to non-lytic virus release. We hypothesize that 329 SV40 released from cells around this time binds to the plasma membrane of the same and 330 neighboring infected cells and induces cell signaling, which in turn stimulates cell lysis and 331 subsequent increased virus release from these cells, thus establishing a positive feedback loop 332 that stimulates further signaling and virus release. This model is similar to our earlier analysis 333 of vacuolization during SV40 infection (17), in which we proposed that the first released virus 334 binds to cell surface GM1 and stimulates vacuole formation late during infection. We extend 335 the model here to include virus release as well as vacuolization as a phenotype that can be 336 acutely triggered late in infection by the first progeny virus released. Thus, the initial wave of 337 released virus primes the infected cell population for more pronounced vacuolization and 338 enhanced virus release. 339
To complete the virus life cycle, polyomaviruses release depends on lysis of the 340 infected cell. Whether cell death is the consequence of plasma membrane rupture resulting 341 from extensive virus production or a regulated process depending on active cellular signaling 342 was heretofore unclear. Here, we show that high levels of intracellular virus are not sufficient 343 for efficient release and that cellular MAPK signaling is necessary for optimal cell lysis and 
Flow cytometry 505
Flow cytometry was done as previously described ((37)). Briefly, to stain for intracellular 506 VP1 and large T antigen, cells were fixed and permeabilized with methanol or 4% PFA/0.5% 507 Triton X-100 and subsequently stained with the primary antibodies PAb 597 and PAb108 508 against VP1 and large T antigen, respectively. Alexa Fluor 488-labeled donkey anti-mouse 509 antibody (Jackson Research) or goat anti-mouse APC were used as secondary antibodies. 
